| Acute Leukemia |
1 |
1 |
| Biologic Therapy |
0 |
0.9 |
| CAR-T |
0 |
0.86 |
| Head and Neck Cancer |
0 |
0.37 |
| Toxicology |
0 |
0.32 |
| Child |
0 |
0.31 |
| Leukemia |
0 |
0.28 |
| Remission |
0 |
0.28 |
| Acute Lymphoblastic Leukemia |
0 |
0.22 |
| Acute Myeloblastic Leukemia |
0 |
0.22 |
| Transplantation |
0 |
0.22 |
| Stem Cell Research and Therapy |
0 |
0.18 |
| Cancer |
0 |
0.16 |
| Genomic Medicine |
0 |
0.16 |
| Cancer in Childhood |
0 |
0.14 |
| Allograft |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| Brain Tumor |
0 |
0.06 |
| Genetics |
0 |
0.06 |
| Antigens |
0 |
0.03 |
| Brain |
0 |
0.03 |
| Central Nervous System |
0 |
0.03 |
| Corticosteroids |
0 |
0.03 |
| Cytokines |
0 |
0.03 |
| Drug Resistance |
0 |
0.03 |
| Fertility |
0 |
0.03 |
| Healthcare and Medical Technology |
0 |
0.03 |
| Hypotension |
0 |
0.03 |
| Medical Innovations |
0 |
0.03 |
| Neurotoxicity |
0 |
0.03 |
| Refractory |
0 |
0.03 |
| Residual Disease |
0 |
0.03 |
| Seizure |
0 |
0.03 |
| Testes |
0 |
0.03 |
| Tumor |
0 |
0.03 |